Search

Urinary energy losses in cats have to be determined in energy balance trials as well as for the calculation of the metabolizable energy (ME) content of cat food. The aim of the present study was: first, to assess whether the energy content of cat urine quantified by bomb calorimetry differs from that quantified using GE (kJ) urine = 33 kJ × g C urine + 9 kJ × g N urine and investigate whether this difference could be attributed to influences of diets. Second, to assess whether the subtraction of 3.1 kJ/g of protein intake used for estimation of metabolizable energy content of cat foods is confirmed as usable. Data from 27 energy and protein balance trials from different studies with complete sampling of urine and faeces (29 cats in part A and 35 cats in part B) were used. Gross energy, carbon and nitrogen were determined in food, faeces and urine. Gross energy values in urine tended to be higher when determined with the formula of Hoffman and Klein compared to bomb calorimetry. The average relative difference of gross energy values between the methods was 18.8%. The mean energy loss in kJ/g of protein intake resulted in 3.7 kJ/g protein intake, which was not statistically significantly different (p = 0.12) from the tested value of 3.1 kJ/g of protein intake. In conclusion, the formula of Hoffman and Klein is not appropriate for the estimation of energy in cat urine. In balance studies, it is advisable to quantify the urinary energy content by bomb calorimetry. In the second part of the study, the protein correction factor to determine ME of 3.1 kJ/g protein intake for urinary energy losses of Kienzle et al. could be confirmed.

Objective To assess the differences in the pharmacokinetic profiles of S-ketamine, R-ketamine and their metabolites, S-norketamine and R-norketamine, and to measure relevant physiologic variables after intravenous administration of racemic (RS) ketamine or S-ketamine alone in Beagle dogs sedated with medetomidine. Study design Experimental, blinded and randomized crossover study. Animals A total of six (three female and three male) adult Beagle dogs. Methods Medetomidine (450 μg m–2) was administered intramuscularly, followed by either S-ketamine (2 mg kg–1) or RS-ketamine (4 mg kg–1) 20 minutes later, both administered intravenously. Blood samples were collected before medetomidine administration and at multiple time points 1–900 minutes following the ketamine administration. Plasma samples were analysed using liquid chromatography–tandem mass spectrometry. Heart rate, respiratory rate, noninvasive blood pressure, haemoglobin saturation with oxygen and body temperature were measured at baseline, before ketamine administration, and 1, 2, 5, 10, 15, 20 and 30 minutes after ketamine administration. All cardiovascular variables, blood glucose, haemoglobin and lactate concentrations were analysed using different linear mixed effects models; the significance was set at p Results S-ketamine showed a two-compartment kinetic profile; no statistically significant differences were observed between its concentrations or in the calculated pharmacokinetic parameters following S- or RS-ketamine. When the racemic mixture was administered, no differences were detected between R- and S-ketamine concentrations, but the area under the curve (AUC) for R-norketamine was significantly lower than that for S-norketamine. Clinically relevant physiologic variables did not show statistically significant differences following the administration of the racemic mixture or of S-ketamine alone. Conclusions and clinical relevance This study performed in dogs showed that RS-ketamine and S-ketamine combined with medetomidine showed enantioselective pharmacokinetics as S- and R-norketamine AUCs were different, but S-ketamine levels were identical.